Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: Biological lessons, current challenges, and clinical perspectives
R.S. is funded in part by the National Institutes of Health (grant no.: CA126809). V.M. is funded by the Italian Association for Cancer Research.
Potential conflict of interest: Dr. Sangro consults and is on the speakers' bureau for Sirtex Medical. Dr. Mazzaferro is on the speakers' bureau for and received grants from Bayer and Nordion. Dr. Salem consults, advises, and is on the speakers' bureau for Nordion. He consults for and advises Bayer and Sirtex Medical.